Effect of folic acid and metformin on insulin resistance and inflammatory factors of obese children and adolescents

Journal of Research in Medical Sciences

Volumn 21, Issue 5, 2016, Pages 32-37

  Dehkordi Hashemi, Elham ^a,b   Sattari, Farnaz ^a   Khoshdel, Abolfazl ^a   Kasiri, Karamali ^a  

^a SHAHREKORD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Children; Folic acid; Homocysteine; Inflammation; Insulin resistance; Metformin; Obese

Indexed keywords

FOLIC ACID; HOMOCYSTEINE; INTERLEUKIN 6; INTERLEUKIN 8; METFORMIN; TUMOR NECROSIS FACTOR;

ANTHROPOMETRY; ARTICLE; AUTOANALYZER; BIOCHEMICAL ANALYSIS; BODY MASS; CHILD; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; IMMUNOASSAY; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; OBESITY; PRESCHOOL CHILD; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD;

EID: 84984993544     PISSN: 17351995     EISSN: 17357136     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Santo Domingo L, Scheimann AO. Overview of the epidemiology and management of childhood obesity. Minerva Pediatr 2012;64:607-613.
2. Barton M. Childhood obesity: A life-long health risk. Acta Pharmacol Sin 2012;33:189-193.
3. Berenson GS; Bogalusa Heart Study Group. Health consequences of obesity. Pediatr Blood Cancer 2012;58:117-121.
4. Staiano AE, Katzmarzyk PT. Ethnic and sex differences in body fat and visceral and subcutaneous adiposity in children and adolescents. Int J Obes (Lond) 2012;36:1261-1269.
5. Caprio S, Hyman LD, McCarthy S, Lange R, Bronson M, Tamborlane WV. Fat distribution and cardiovascular risk factors in obese adolescent girls: Importance of the intraabdominal fat depot. Am J Clin Nutr 1996;64:12-17.
6. Güngör NK. Overweight and obesity in children and adolescents. J Clin Res Pediatr Endocrinol 2014;6:129-143.
7. Aye T, Levitsky LL. Type 2 diabetes: An epidemic disease in childhood. Curr Opin Pediatr 2003;15:411-415.
8. Hill MF. Emerging role for antioxidant therapy in protection against diabetic cardiac complications: Experimental and clinical evidence for utilization of classic and new antioxidants. Curr Cardiol Rev 2008;4:259-268.
9. Evans JL. Antioxidants: Do they have a role in the treatment of insulin resistance? Indian J Med Res 2007;125:355-372.
10. Evans JL, Goldfine ID, Maddux BA, Grodsky GM. Oxidative stress and stress-activated signaling pathways: A unifying hypothesis of type 2 diabetes. Endocr Rev 2002;23:599-622.
11. Gariballa S, Afandi B, Abuhaltem M, Yassin J, Habib H, Ibrahim W. Oxidative damage and inflammation in obese diabetic Emirati subjects supplemented with antioxidants and B-Vitamins: A randomized placebo-controlled trail. Nutr Metab (Lond) 2013;10:21.
12. Montero D, Walther G, Stehouwer CD, Houben AJ, Beckman JA, Vinet A. Effect of antioxidant vitamin supplementation on endothelial function in type 2 diabetes mellitus: A systematic review and meta-analysis of randomized controlled trials. Obes Rev 2014;15:107-116.
13. Freemark M. Pharmacotherapy of childhood obesity: An evidence-based, conceptual approach. Diabetes Care 2007;30:395-402.
14. McDonagh MS, Selph S, Ozpinar A, Foley C. Systematic review of the benefits and risks of metformin in treating obesity in children aged 18 years and younger. JAMA Pediatr 2014;168:178-184.
15. Lonn E, Yusuf S, Arnold MJ, Sheridan P, Pogue J, Micks M, et al. Homocysteine lowering with folic acid and B Vitamins in vascular disease. N Engl J Med 2006;354:1567-1577.
16. Petkar R, Wright N. Pharmacological management of obese child. Arch Dis Child Educ Pract Ed 2013;98:108-112.
17. Matson KL, Fallon RM. Treatment of obesity in children and adolescents. J Pediatr Pharmacol Ther 2012;17:45-57.
18. Jafari-Adli S, Jouyandeh Z, Qorbani M, Soroush A, Larijani B, Hasani-Ranjbar S. Prevalence of obesity and overweight in adults and children in Iran; a systematic review. J Diabetes Metab Disord 2014;13:121.
19. Atabek ME, Bağcı Z, Pirgon Ö, Erkul İ. Plasma total homocysteine levels in childhood obesity. Turk J Endocrinol Metab 2004;3:107-111.
20. Martos R, Valle M, Morales R, Cañete R, Gavilan MI, Sánchez-Margalet V. Hyperhomocysteinemia correlates with insulin resistance and low-grade systemic inflammation in obese prepubertal children. Metabolism 2006;55:72-77.
21. Yanovski JA, Krakoff J, Salaita CG, McDuffie JR, Kozlosky M, Sebring NG, et al. Effects of metformin on body weight and body composition in obese insulin-resistant children: A randomized clinical trial. Diabetes 2011;60:477-485.
22. Kendall D, Vail A, Amin R, Barrett T, Dimitri P, Ivison F, et al. Metformin in obese children and adolescents: The MOCA trial. J Clin Endocrinol Metab 2013;98:322-329.
23. Park MH, Kinra S, Ward KJ, White B, Viner RM. Metformin for obesity in children and adolescents: A systematic review. Diabetes Care 2009;32:1743-1745.
24. Gómez-Díaz RA, Talavera JO, Pool EC, Ortiz-Navarrete FV, Solórzano-Santos F, Mondragón-González R, et al. Metformin decreases plasma resistin concentrations in pediatric patients with impaired glucose tolerance: A placebo-controlled randomized clinical trial. Metabolism 2012;61:1247-1255.
25. Evia-Viscarra ML, Rodea-Montero ER, Apolinar-Jiménez E, Muñoz-Noriega N, García-Morales LM, Leaños-Pérez C, et al. The effects of metformin on inflammatory mediators in obese adolescents with insulin resistance: Controlled randomized clinical trial. J Pediatr Endocrinol Metab 2012;25:41-49.
26. Pongchaidecha M, Srikusalanukul V, Chattananon A, Tanjariyaporn S. Effect of metformin on plasma homocysteine, Vitamin B12 and folic acid: A cross-sectional study in patients with type 2 diabetes mellitus. J Med Assoc Thai 2004;87:780-787.
27. Sahin M, Tutuncu NB, Ertugrul D, Tanaci N, Guvener ND. Effects of metformin or rosiglitazone on serum concentrations of homocysteine, folate, and Vitamin B12 in patients with type 2 diabetes mellitus. J Diabetes Complications 2007;21:118-123.
28. Iamopas O, Ratanachu-ek S, Chomtho S. Effect of folic acid supplementation on plasma homocysteine in obese children: A randomized, double-blind, placebo-controlled trial. J Med Assoc Thai 2014;97 Suppl 6:S195-S204.
29. Gargari BP, Aghamohammadi V, Aliasgharzadeh A. Effect of folic acid supplementation on biochemical indices in overweight and obese men with type 2 diabetes. Diabetes Res Clin Pract 2011;94:33-38.
30. Solini A, Santini E, Ferrannini E. Effect of short-term folic acid supplementation on insulin sensitivity and inflammatory markers in overweight subjects. Int J Obes (Lond) 2006;30:1197-1202.
31. Peña AS, Wiltshire E, Gent R, Piotto L, Hirte C, Couper J. Folic acid does not improve endothelial function in obese children and adolescents. Diabetes Care 2007;30:2122-21227.
32. Papandreou D, Malindretos P, Arvanitidou M, Makedou A, Rousso I. Oral supplementation of folic acid for two months reduces total serum homocysteine levels in hyperhomocysteinemic Greek children. Hippokratia 2010;14:105-108.
33. Zabaleta J, Velasco-Gonzalez C, Estrada J, Ravussin E, Pelligrino N, Mohler MC, et al. Inverse correlation of serum inflammatory markers with metabolic parameters in healthy, black and white prepubertal youth. Int J Obes (Lond) 2014;38:563-568.
34. Galcheva SV, Iotova VM, Yotov YT, Bernasconi S, Street ME. Circulating proinflammatory peptides related to abdominal adiposity and cardiometabolic risk factors in healthy prepubertal children. Eur J Endocrinol 2011;164:553-558.
35. Roth CL, Kratz M, Ralston MM, Reinehr T. Changes in adipose-derived inflammatory cytokines and chemokines after successful lifestyle intervention in obese children. Metabolism 2011;60:445-452.
36. Bugge A, El-Naaman B, McMurray RG, Froberg K, Nielsen CH, Müller K, et al. Sex differences in the association between level of childhood interleukin-6 and insulin resistance in adolescence. Exp Diabetes Res 2012;2012:859186.